AR090726A1 - Vacunas y procedimientos para tratar la enfermedad de lyme en perros - Google Patents
Vacunas y procedimientos para tratar la enfermedad de lyme en perrosInfo
- Publication number
- AR090726A1 AR090726A1 ARP130101267A ARP130101267A AR090726A1 AR 090726 A1 AR090726 A1 AR 090726A1 AR P130101267 A ARP130101267 A AR P130101267A AR P130101267 A ARP130101267 A AR P130101267A AR 090726 A1 AR090726 A1 AR 090726A1
- Authority
- AR
- Argentina
- Prior art keywords
- vaccines
- dogs
- procedures
- disease
- immunogenic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261635031P | 2012-04-18 | 2012-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090726A1 true AR090726A1 (es) | 2014-12-03 |
Family
ID=48193279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101267A AR090726A1 (es) | 2012-04-18 | 2013-04-17 | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2838555A2 (ja) |
JP (1) | JP2015514776A (ja) |
CN (1) | CN104379164A (ja) |
AR (1) | AR090726A1 (ja) |
AU (1) | AU2013249229A1 (ja) |
BR (1) | BR112014025740A2 (ja) |
CA (1) | CA2870179C (ja) |
EA (1) | EA201491668A1 (ja) |
UY (1) | UY34745A (ja) |
WO (1) | WO2013158818A2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10086057B2 (en) | 2014-10-08 | 2018-10-02 | Virginia Commonwealth University | Stage specific diagnostic antigens, assay and vaccine for lyme disease |
US11883476B2 (en) | 2017-12-04 | 2024-01-30 | Intervet Inc. | Canine lyme disease vaccine |
CN110483624B (zh) * | 2019-08-22 | 2021-02-09 | 中国疾病预防控制中心传染病预防控制所 | 伽氏疏螺旋体OspA蛋白C端肽段及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567042A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US6872550B1 (en) | 1991-07-11 | 2005-03-29 | Baxter Vaccine Ag | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
US6113914A (en) * | 1991-08-15 | 2000-09-05 | Smithkline Beecham Biologicals (S.A.) | Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
ATE386805T1 (de) | 1998-07-31 | 2008-03-15 | Gundersen Lutheran Medical Fou | Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff |
US20110262475A1 (en) * | 2008-05-02 | 2011-10-27 | Earnhart Christopher G | Lyme disease vaccine |
WO2010132758A2 (en) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Ospc-based diagnostic test for lyme disease |
EP3029073B1 (en) * | 2010-10-20 | 2019-09-04 | Virginia Commonwealth University | Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
-
2013
- 2013-04-16 UY UY0001034745A patent/UY34745A/es not_active Application Discontinuation
- 2013-04-17 AR ARP130101267A patent/AR090726A1/es unknown
- 2013-04-18 CN CN201380030342.1A patent/CN104379164A/zh active Pending
- 2013-04-18 JP JP2015507162A patent/JP2015514776A/ja active Pending
- 2013-04-18 EA EA201491668A patent/EA201491668A1/ru unknown
- 2013-04-18 EP EP13719257.1A patent/EP2838555A2/en not_active Withdrawn
- 2013-04-18 WO PCT/US2013/037063 patent/WO2013158818A2/en active Application Filing
- 2013-04-18 BR BR112014025740A patent/BR112014025740A2/pt not_active IP Right Cessation
- 2013-04-18 AU AU2013249229A patent/AU2013249229A1/en not_active Abandoned
- 2013-04-18 CA CA2870179A patent/CA2870179C/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2013158818A2 (en) | 2013-10-24 |
JP2015514776A (ja) | 2015-05-21 |
UY34745A (es) | 2013-11-29 |
EP2838555A2 (en) | 2015-02-25 |
BR112014025740A2 (pt) | 2017-07-04 |
CA2870179A1 (en) | 2013-10-24 |
AU2013249229A1 (en) | 2014-10-23 |
CN104379164A (zh) | 2015-02-25 |
EA201491668A1 (ru) | 2015-08-31 |
CA2870179C (en) | 2018-09-04 |
WO2013158818A3 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267997A (en) | Preparations, formulations and methods for treating eye diseases | |
MX340739B (es) | Quimeras ospa y su uso en vacunas. | |
BR112012005225B8 (pt) | Uso de uma proteína de fusão actriib-fc para o tratamento de um transtorno relacionado ao osso ou associado à perda de músculo por crescimento muscular insuficiente | |
CO7151522A2 (es) | Proteínas de fusión de interleuquina-10 y usos de las mismas | |
CO7160093A2 (es) | Anticuerpos anti-egfr y usos de los mismos | |
PH12015500092A1 (en) | Compositions for immunising against staphylococcus aureus | |
IL257057A (en) | Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine | |
MX2015011199A (es) | Agentes terapéuticos de csf1. | |
BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
EP3845241A8 (en) | Long lasting effect of new botulinum toxin formulations | |
DOP2013000235A (es) | Proteínas de fusión y vacunas de combinación que comprenden proteína e y pilina a de haemophilus influenzae. | |
BR112016013109A2 (pt) | anticorpos de anti-siglec-8 e métodos de seu uso | |
CL2015003343A1 (es) | Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico. | |
IN2015DN02729A (ja) | ||
BR112018013756A2 (pt) | suturas cirúrgicas para aumentar a pele | |
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
UA114286C2 (uk) | Спосіб лікування staphylococcus aureus | |
MX2017005687A (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
AR094851A1 (es) | COMPUESTOS BICíCLICOS COMO AGONISTAS DE S1P₁ | |
WO2015084883A3 (en) | Compositions and methods for treating osteoarthritis | |
BR112015016033A8 (pt) | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos | |
BR112015001843A2 (pt) | dispositivo médico, composição de matriz biodegradável e método para tratar um paciente. | |
CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
AR090726A1 (es) | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |